Correlation Between Virax Biolabs and MediciNova

Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and MediciNova at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and MediciNova into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Virax Biolabs Group and MediciNova, you can compare the effects of market volatilities on Virax Biolabs and MediciNova and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of MediciNova. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and MediciNova.

Diversification Opportunities for Virax Biolabs and MediciNova

-0.35

Correlation Coefficient

Virax Biolabs  MediciNova

Very good diversification

The 3 months correlation between Virax and MediciNova is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and MediciNova in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MediciNova and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with MediciNova. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MediciNova has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and MediciNova go up and down completely randomly.

Pair Corralation between Virax Biolabs and MediciNova

Given the investment horizon of 90 days Virax Biolabs is expected to generate 1.34 times less return on investment than MediciNova. In addition to that, Virax Biolabs is 1.39 times more volatile than MediciNova. It trades about 0.02 of its total potential returns per unit of risk. MediciNova is currently generating about 0.05 per unit of volatility. If you would invest  202.00  in MediciNova on September 25, 2024 and sell it today you would earn a total of  15.00  from holding MediciNova or generate 7.43% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Virax Biolabs Group  vs.  MediciNova

Virax Biolabs Group

Risk-Adjusted Performance

1 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Virax Biolabs Group are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Virax Biolabs showed solid returns over the last few months and may actually be approaching a breakup point.

MediciNova

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in MediciNova are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, MediciNova showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Virax Biolabs and MediciNova

The main advantage of trading using opposite Virax Biolabs and MediciNova positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, MediciNova can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MediciNova will offset losses from the drop in MediciNova's long position.

The idea behind Virax Biolabs Group and MediciNova pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.